nivolumab,ipilimumab
bms
[]
checkmate-649 study findings continue to support frontline #nivolumab and #chemotherapy for patients with advanced gastric, gastroesophageal junction cancer, and esophageal adenocarcinoma. #gicsm #gi23 | 
Oncology news and insights from leading researchers and cancer centers.